Form 8-K - Current report:
SEC Accession No. 0001601830-25-000040
Filing Date
2025-03-18
Accepted
2025-03-18 08:01:29
Documents
15
Period of Report
2025-03-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rxrx-20250315.htm   iXBRL 8-K 35517
2 EX-10.1 exhibit101-outsidedirector.htm EX-10.1 46132
3 EX-99.1 exhibit991-pressrelease.htm EX-99.1 13283
  Complete submission text file 0001601830-25-000040.txt   233506

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20250315.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20250315_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20250315_pre.xml EX-101.PRE 12512
17 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20250315_htm.xml XML 2746
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 25746528
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)